Home/Filings/4/0001209191-22-002918
4//SEC Filing

Forster Eliot 4

Accession 0001209191-22-002918

CIK 0001566373other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 5:27 PM ET

Size

5.9 KB

Accession

0001209191-22-002918

Insider Transaction Report

Form 4
Period: 2022-01-09
Forster Eliot
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-09+165,028165,028 total
    Exercise: $4.77Exp: 2032-01-09Common Stock (165,028 underlying)
Footnotes (2)
  • [F1]These options were granted under the Issuer's 2019 Equity Incentive Plan.
  • [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, January 9, 2022, and thereafter in 36 equal monthly installments such that the stock option shall be fully-vested on the fourth annual anniversary of the Vesting Commencement Date.

Issuer

F-star Therapeutics, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001831558

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 5:27 PM ET
Size
5.9 KB